Clinical Trial Update: Percutaneous Device Closure for Significant Paravalvular Leakage After Transcatheter or Surgical Valve Replacement [NA]

View source ↗

Summary

A clinical trial evaluating percutaneous device closure for significant paravalvular leakage after transcatheter or surgical valve replacement has been withdraw…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Valvular Heart Disease
• Valvular Insufficiency

Snippet

Sponsor: Seung-Jung Park | Conditions: Cardiac Valves, Heart Valve Diseases | NA | Status: WITHDRAWN